Single-chain variable fragment affinity tuning can optimize anti-AML CAR-NK cell functionality
Journal for ImmunoTherapy of Cancer · 2025-02 · 13 (2) · e010763
DOI: 10.1136/jitc-2024-010763 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, online erschienen am 06.02.2025. Verfasst von Ruyan Rahnama und 15 weiteren Autor:innen. Beteiligte Einrichtung: Oncology, Johns Hopkins Medicine Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Killer Cells, Natural, Leukemia, Myeloid, Acute, Receptors, Chimeric Antigen, Single-Chain Antibodies. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIBIB NIH HHS, NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Background
Natural Killer (NK) cells have intrinsic anticancer activity that can be redirected toward acute myeloid leukemia (AML) with chimeric antigen receptor (CAR) engineering. Here, we study the functional consequences of CAR binding affinity and targeted epitope on CAR-NK cell activation, cytolytic synapse formation, and antitumor activity.
Methods
We characterized NK-92 and primary NK cell populations expressing variant affinity AML-specific CARs containing single-chain variable fragments (scFvs, 26292 or 7G3) targeting two epitopes on CD123. 26292 affinity variants were discovered through directed evolution of an error-prone mutagenic library, while 7G3 affinity variants were previously reported. The resulting CAR-NK cell panel was studied with in vitro binding, activation, and cytotoxicity studies and in mouse xenograft models.
Results
26292 and 7G3 CARs of variable CD123 binding affinities were highly expressed in NK cells and conferred antigen-specific activation in vitro. High-resolution imaging demonstrated greater clustering of high-affinity 7G3 CAR-NK cells and consequent AML target cell death in a short-term time lapse. Low-affinity 7G3 CAR-NK cells exhibited enhanced antigen density discrimination with greater membrane-proximal signaling, cytokine production, and cytotoxicity. In longer-term assays, low-affinity 7G3 CAR-NK cells demonstrated more sustained killing of AML cells. In vivo testing highlighted greater expansion of low-affinity 7G3 CAR-NK cells in two xenograft models.
Conclusions
Expression of 26292 and 7G3 CARs with a range of CD123 binding affinities in NK cells leads to antigen-specific activation and cytotoxicity against AML. Affinity-based differences in functional activation and antitumor activity are dependent on time course and are scFv/epitope specific.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Oncology, Johns Hopkins Medicine Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USA.
- Department of Biomedical Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Department of Chemical and Biomolecular Engineering, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Oncology, Johns Hopkins Medicine Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USA cbonifa2@jhmi.edu jamie.spangler@jhu.edu.
- Bloomberg~Kimmel Institute for Cancer Immunotherapy, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
- Ophthalmology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Förderung
- NIBIB NIH HHS
- NIH HHS
- NCI NIH HHS
- Alex's Lemonade Stand Foundation for Childhood Cancer
- National Science Foundation Graduate Research Fellowship Program
- Office of the Director of the National Institute of Health
- Allegheny Health Network
- St. Baldrick's Foundation
Zitieren
APA
Rahnama, R., Kizerwetter, M., Yang, H., Christodoulou, I., Guaraca, C., Holl, N. J., Choe, J., Vorri, S. C., Zinsky, M., Jones, D. G., Garcia Espinoza, N., Kuo, Y. H., Zahurak, M., Varadhan, R., Spangler, J. B., & Bonifant, C. L. (2025). Single-chain variable fragment affinity tuning can optimize anti-AML CAR-NK cell functionality. Journal for ImmunoTherapy of Cancer, 13(2), e010763. https://doi.org/10.1136/jitc-2024-010763
Vancouver
Rahnama R, Kizerwetter M, Yang H, Christodoulou I, Guaraca C, Holl NJ, et al. Single-chain variable fragment affinity tuning can optimize anti-AML CAR-NK cell functionality. Journal for ImmunoTherapy of Cancer. 2025;13(2):e010763. doi:10.1136/jitc-2024-010763
BibTeX
@article{Rahnama2025,
author = {Rahnama, Ruyan and Kizerwetter, Monika and Yang, Huilin and Christodoulou, Ilias and Guaraca, Christian and Holl, Natalie Jordan and Choe, Jun and Vorri, Stamatia C and Zinsky, Megan and Jones, Danielle G and Garcia Espinoza, Nikol and Kuo, Yun-Huai and Zahurak, Marianna and Varadhan, Ravi and Spangler, Jamie B and Bonifant, Challice L},
title = {Single-chain variable fragment affinity tuning can optimize anti-AML CAR-NK cell functionality},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2025},
volume = {13},
number = {2},
pages = {e010763},
doi = {10.1136/jitc-2024-010763}
}
EUVIMED